Oramed Pharmaceuticals (ORMP) Change in Acquisitions & Divestments (2010 - 2026)

Oramed Pharmaceuticals' Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 87.62% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.1 million (down 119.95% YoY) and the FY2025 annual result came in at $2.9 million, down 97.05% from the prior year.
• Change in Acquisitions & Divestments was $3.5 million for Q1 2026 at Oramed Pharmaceuticals, up from -$47.6 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $124.2 million in Q3 2022 and bottomed at -$47.6 million in Q4 2025.
• A 5-year average of $17.8 million and a median of $4.8 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Peak annual rise in Change in Acquisitions & Divestments reached 2370.05% in 2025, while the deepest fall reached 237.0% in 2025.
• Oramed Pharmaceuticals' Change in Acquisitions & Divestments stood at $50.2 million in 2022, then sank by 98.71% to $650000.0 in 2023, then surged by 9154.15% to $60.2 million in 2024, then slumped by 179.11% to -$47.6 million in 2025, then jumped by 107.4% to $3.5 million in 2026.
• Business Quant data shows ORMP's Change in Acquisitions & Divestments at $3.5 million in Q1 2026, -$47.6 million in Q4 2025, and $49.4 million in Q3 2025.